Buch, Englisch, 281 Seiten, Previously published in hardcover, Format (B × H): 155 mm x 235 mm, Gewicht: 446 g
Buch, Englisch, 281 Seiten, Previously published in hardcover, Format (B × H): 155 mm x 235 mm, Gewicht: 446 g
Reihe: Cancer Treatment and Research
ISBN: 978-1-4899-9680-0
Verlag: Springer US
Hormone Receptors in Breast Cancer provides an up-to-date resource of the role of hormone receptors in breast cancer written in depth for both the basic molecular academic researcher and translational scientist. Advances in basic science of molecular endocrinology have undoubtedly been translated into clinical practice, and clinicians caring for this disease need to be knowledgeable about these developments. The molecular basis of hormone action has been elucidated, and the relative significance of the different estrogen and progesterone receptor isoforms has been explored. This explosion of information has lead to exciting new areas of gene specific targeting of the disease, and breast cancer prevention. Paradigm shifts in treatment options and sequencing have recently occurred in breast cancer management, necessitating close cooperation and communication between translational scientists and physicians. This book is focused on providing this communication.
Zielgruppe
Professional/practitioner
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Molekulare Medizin, Zellbiologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Endokrinologie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Gynäkologie, Geburtshilfe
Weitere Infos & Material
Hormone Action and Clinical Significance of the Estrogen Receptor #x03B1;.- Role of ER#x03B2; in Clinical Breast Cancer.- Hormone Action and Breast Cancer.- Estrogen Receptors in Breast Tumors of African American Patients.- BRCA1 Cross-Talk with Hormone Receptors.- Metastasis of Hormone Receptor Positive Breast Cancer.- Endocrine Therapy with Selective Estrogen Receptor Modulators (SERMs) and Aromatase Inhibitors in the Prevention and Adjuvant Therapy Settings.- Biomarkers in Neoadjuvant Trials.- Hormone Resistance.- Strategies of Hormonal Prevention.- Estrogen Receptor Phenotypes Defined by Gene Expression Profiling.
